NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $10,860,000 | +100.4% | 303,608 | +45.7% | 0.66% | +74.3% |
Q3 2014 | $5,418,000 | +8.3% | 208,385 | +37.7% | 0.38% | +12.2% |
Q2 2014 | $5,003,000 | +16.9% | 151,369 | +5.9% | 0.34% | +7.3% |
Q1 2014 | $4,280,000 | -9.2% | 142,992 | -8.0% | 0.31% | -7.6% |
Q4 2013 | $4,716,000 | +156.9% | 155,348 | +169.1% | 0.34% | +93.2% |
Q3 2013 | $1,836,000 | +60.5% | 57,732 | -23.7% | 0.18% | +55.8% |
Q2 2013 | $1,144,000 | – | 75,681 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |